Reply: Clinical efficacy of lenvatinib for the treatment of radioiodine‐refractory thyroid carcinoma: A systematic review and meta‐analysis of clinical trials
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Endocrinology"
DOI: 10.1111/cen.14718
Abstract: Dear Editor, we read with great interest the paper by Zhipeng et al, sharing the perspective that lenvatinib is beneficial for the treatment of radioiodine-refractory thyroid cancer in terms of the extension of progression-free survival… read more here.
Keywords: radioiodine refractory; treatment radioiodine; refractory thyroid;
Treatment of radioiodine refractory high-differentiated thyroid cancer with lenvatinib.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e17518
Abstract: e17518Background:Long time the patients with high-differentiated thyroid cancer with distant metastases had only one type of treatment. It was radioiodine therapy courses and follow-up. In cases of... read more here.
Keywords: high differentiated; differentiated thyroid; treatment radioiodine; thyroid cancer ... See more keywords